Citation: Ra. Lahti et al., D-2-FAMILY RECEPTORS IN SCHIZOPHRENIA - DISTRIBUTION AND IMPLICATIONSFOR TREATMENT, Clinical neuropharmacology, 18, 1995, pp. 110-120
Citation: T. Kakigi et al., DRUG-INDUCED ORAL DYSKINESIAS IN RATS AFTER TRADITIONAL AND NEW NEUROLEPTICS, Journal of neural transmission, 101(1-3), 1995, pp. 41-49
Citation: Xm. Gao et Ca. Tamminga, MK801 INDUCES LATE REGIONAL INCREASES IN NMDA AND KAINATE RECEPTOR-BINDING IN RAT-BRAIN, Journal of neural transmission, 101(1-3), 1995, pp. 105-113
Citation: Ca. Tamminga et al., GLUTAMATE PHARMACOLOGY AND THE TREATMENT OF SCHIZOPHRENIA - CURRENT STATUS AND FUTURE-DIRECTIONS, International clinical psychopharmacology, 10, 1995, pp. 29-37
Authors:
ROSS DE
THAKER GK
HOLCOMB HH
CASCELLA NG
MEDOFF DR
TAMMINGA CA
Citation: De. Ross et al., ABNORMAL SMOOTH-PURSUIT EYE-MOVEMENTS IN SCHIZOPHRENIC-PATIENTS ARE ASSOCIATED WITH CEREBRAL GLUCOSE-METABOLISM IN OCULOMOTOR REGIONS, Psychiatry research, 58(1), 1995, pp. 53-67
Authors:
HOLCOMB HH
RITZL EK
MEDOFF DR
NEVITT J
GORDON B
TAMMINGA CA
Citation: Hh. Holcomb et al., TONE DISCRIMINATION PERFORMANCE IN SCHIZOPHRENIC-PATIENTS AND NORMAL VOLUNTEERS - IMPACT OF STIMULUS-PRESENTATION LEVELS AND FREQUENCY DIFFERENCES, Psychiatry research, 57(1), 1995, pp. 75-82
Authors:
CARPENTER WT
CONLEY RR
BUCHANAN RW
BREIER A
TAMMINGA CA
Citation: Wt. Carpenter et al., PATIENT RESPONSE AND RESOURCE-MANAGEMENT - ANOTHER VIEW OF CLOZAPINE TREATMENT OF SCHIZOPHRENIA, The American journal of psychiatry, 152(6), 1995, pp. 827-832
Citation: Hh. Holcomb et Ca. Tamminga, NEUROIMAGING .2. REGIONAL CEREBRAL BLOOD-FLOW WITH (H2O)-O-15, The American journal of psychiatry, 152(11), 1995, pp. 1562-1562
Authors:
CASCELLA NG
TARAZI FI
SHIRAKAWA O
TAMMINGA CA
Citation: Ng. Cascella et al., SAVOXEPINE FAILS TO SELECTIVELY INFLUENCE GLUCOSE-METABOLISM IN THE RAT LIMBIC SYSTEM, Psychopharmacology, 114(2), 1994, pp. 275-280
Authors:
LAHTI RA
EVANS DL
FIGUR LM
STRATMAN NC
GILL GS
TAMMINGA CA
Citation: Ra. Lahti et al., DOPAMINE D4 VS DOPAMINE D2 RECEPTOR OCCUPANCY - POSSIBLE THERAPEUTIC IMPLICATIONS, Schizophrenia research, 11(2), 1994, pp. 108-109
Authors:
LAHTI AC
LAPORTE DJ
MOKRISKI B
TAMMINGA CA
Citation: Ac. Lahti et al., COMPARISON OF THE EFFECTS OF THE NMDA ANTAGONIST KETAMINE IN HALOPERIDOL-TREATED AND DRUG-FREE SCHIZOPHRENIC-PATIENTS, Schizophrenia research, 11(2), 1994, pp. 109-109